FUNI — Hypha Labs Income Statement
0.000.00%
Last trade - 00:00- $5.80m
- $7.14m
Annual income statement for Hypha Labs, fiscal year end - September 30th, USD millions except per share, conversion factor applied.
2020 September 30th | 2021 September 30th | R2022 September 30th | 2023 September 30th | 2024 September 30th | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 2.57 | 2.5 | 0 | 0 | 0 |
| Cost of Revenue | |||||
| Gross Profit | 0.796 | 0.715 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 4.77 | 3.05 | 1.15 | 0.492 | 2.78 |
| Operating Profit | -2.19 | -0.55 | -1.15 | -0.492 | -2.78 |
| Gain / Loss on Sale of Assets | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -2.31 | -0.686 | -2.18 | -0.682 | -1.36 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -2.31 | -0.686 | -2.18 | -0.682 | -1.37 |
| Net Income Before Extraordinary Items | |||||
| Extraordinary Items | |||||
| Net Income | -2.31 | -0.686 | -2.06 | 0.247 | -0.785 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -2.31 | -0.686 | -2.25 | 0.247 | -0.785 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.03 | -0.014 | -0.032 | -0.007 | -0.017 |